Wellington Management Group LLP 89bio, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in 89bio, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 319,045 shares of ETNB stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

319,045

Previous 357,536 10.77%

Holding current value

$2.45 Million

Previous $2.86 Million 17.57%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.36 - $9.66 $283,293 - $371,823	-38,491 Reduced 10.77%	319,045 $2.36 Million
Q2 2024 Aug 13, 2024	BUY	$7.31 - $10.9 $362,663 - $540,770	49,612 Added 16.11%	357,536 $2.86 Million
Q1 2024 May 15, 2024	BUY	$8.13 - $13.77 $2.5 Million - $4.24 Million	307,924 New	307,924 $3.58 Million
Q4 2023 Feb 12, 2024	BUY	$6.66 - $16.03 $1.59 Million - $3.83 Million	239,027 New	239,027 $2.67 Million
Q1 2023 May 12, 2023	BUY	$10.48 - $16.94 $638,399 - $1.03 Million	60,916 New	60,916 $927,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $4.02 $3.72 Million - $7.16 Million	-1,782,053 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.45 - $14.99 $1.27 Million - $5.52 Million	-368,422 Reduced 17.13%	1,782,053 $6.72 Million
Q4 2021 Feb 11, 2022	BUY	$11.15 - $19.66 $5.07 Million - $8.94 Million	454,723 Added 26.82%	2,150,475 $28.1 Million
Q3 2021 Nov 15, 2021	BUY	$14.91 - $21.31 $7.24 Million - $10.3 Million	485,431 Added 40.11%	1,695,752 $33.2 Million
Q2 2021 Aug 16, 2021	BUY	$17.42 - $28.0 $1.62 Million - $2.61 Million	93,195 Added 8.34%	1,210,321 $22.6 Million
Q1 2021 May 17, 2021	SELL	$20.22 - $26.73 $2.99 Million - $3.95 Million	-147,785 Reduced 11.68%	1,117,126 $26.5 Million
Q4 2020 Feb 12, 2021	SELL	$23.16 - $28.08 $12.9 Million - $15.7 Million	-558,088 Reduced 30.61%	1,264,911 $30.8 Million
Q3 2020 Nov 16, 2020	BUY	$24.34 - $38.82 $21.1 Million - $33.6 Million	865,882 Added 90.47%	1,822,999 $46.8 Million
Q2 2020 Aug 14, 2020	SELL	$19.93 - $31.2 $139,589 - $218,524	-7,004 Reduced 0.73%	957,117 $19.1 Million
Q1 2020 May 14, 2020	BUY	$16.4 - $41.77 $674,400 - $1.72 Million	41,122 Added 4.46%	964,121 $24.3 Million
Q4 2019 Feb 11, 2020	BUY	$19.75 - $33.44 $18.2 Million - $30.9 Million	922,999 New	922,999 $24.3 Million

Others Institutions Holding ETNB

# of Institutions

158

Shares Held

108M

Call Options Held

73.6K

Put Options Held

1.19M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $357M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP 89bio, Inc. Transaction History